New SEC Form D filing

HYKU BIOSCIENCES INC., 2026-08-13

A new SEC Form D private-offering notice from Concord, MA, a $8,612,446 filer-stated offering target in Biotech. The source filing is one click away.

What this filing says

HYKU BIOSCIENCES INC. site↗ Verified via SEC Form D

Biotech developing a covalent medicines discovery platform that targets non-cysteine amino acids for oncology drug discovery.

Filed 6 days agoFiled to raise $8,612,446First money in 2026-07-30Raised so far $8,612,446HQ (as filed) Concord, MASector Biotech web-verified against the company’s own siteStage (inferred) EarlyCall status Call-ready
Source linked the Form D on EDGAR↗Website verified hykubiosciences.com↗Named in the filing 4 executives & directors
Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source